HHS launches clinical trial reforms — including new pilot programs and updated FDA guidance — to accelerate US drug development and compete with China.
HHS Secretary Robert F. Kennedy Jr. (AP Photo/Jacquelyn Martin)
June 22, 2026 02:45 PM EDT
R&DPharmaFDA+
HHS rolls out sweeping clinical trial reforms to counter China, RFK Jr. says
Max Bayer
HHS proposes plan to speed up clinical trials
Trump administration moves to increase early-stage clinical trials
FDA to launch pilot program to speed up early-stage clinical trials
HHS, responding to China’s rise, moves to fast-track early drug research
RFK Jr.'s Vax Agenda Lives; Filler 'Smuggling' Accusations; Peptide Gray Market
Operation TrialBlazer: US FDA updates guidance to speed up drug development
HHS Secretary Robert F. Kennedy Jr. wants to speed up clinical trials in the United States.“A recent study found that China…
The FDA and the NIH are streamlining clinical trial research guidelines to bolster U.S. biotech, calling it "Operation Trial…
Operation TrialBlazer aims to accelerate U.S. clinical research and counter China’s, but RFK Jr.’s hostility toward mRNA…
U.S. clinical trials continue to lose ground to China, but is Operation Trialblazer enough to help America catch up?
Federal health officials aim to speed up drug development and better compete with China.
A series of newly planned reforms are designed to entice companies to start early trials in the U.S. rather than overseas.
